ML19025A267

From kanterella
Revision as of 07:22, 6 November 2019 by StriderTol (talk | contribs) (Created page by program invented by StriderTol)
Jump to navigation Jump to search
Enclosure 6 - Meeting Slides for the January 29 and 30, 2019 Meeting Between Shine Medical Technologies, Inc. and the NRC - Shine Identification of Safety-Related Controls
ML19025A267
Person / Time
Site: SHINE Medical Technologies
Issue date: 01/22/2019
From: Olvera J
SHINE Medical Technologies
To:
Office of Nuclear Reactor Regulation
References
2019-SMT-0006
Download: ML19025A267 (12)


Text

ENCLOSURE 6 SHINE MEDICAL TECHNOLOGIES, INC.

MEETING SLIDES FOR THE JANUARY 29 AND 30, 2019 MEETING BETWEEN SHINE MEDICAL TECHNOLOGIES, INC. AND THE NRC SHINE IDENTIFICATION OF SAFETY-RELATED CONTROLS PUBLIC VERSION 11 pages follow

Identification of Safety-Related Controls John Olver~, Safety Analysis Manager Health. llluminatedT:

Summary

  • Methodology for Integrated Safety Analysis
  • Current status of Integrated Safety Analysis
  • Example Process Hazard Analysis Accident Sequences
  • Discussion of preliminary list of safety-related controls
  • Review of detailed tables of safety-related controls SHINE Medical Technologies I2

Methodology for the Integrated Safety Analysis

  • The Integrated Safety Analysis (ISA) is prepared in accordance with the requirements of Subpart Hof 10 CFR Part 70
  • Guidance documents SHINE used in the preparation of the ISA include:
  • NUREG-1513, "Integrated Safety Analysis Guidance Document"
  • NUREG-1520, "Standard Review Plan for Fuel Cycle Facilities License Applications"
  • Final Interim Staff Guidance Augmenting NUREG-1537
  • NUREG/CR-6410, "Nuclear Fuel Cycle Facility Accident Analysis Handbook" SHINE Medical Technologies I 3

Methodology for the Integrated Safety Analysis

  • Process Hazard Analyses (PHA) accident sequence development:
  • Based on hazard evaluation results and the guidance provided in the Interim Staff Guidance Augmenting NUREG-1537
  • Estimate an uncontrolled risk index for each potential accident sequence (likelihood x unmitigated consequences)
  • Identified engineered and administrative controls for those scenarios which have an unacceptable risk
  • Evaluate controlled risk indices crediting risk reduction from controls
  • Develop list of safety-related controls SHINE Medical Technologies I4

Methodology for the Integrated Safety Analysis

  • Types of Controls - Safety-related
  • Active Engineered Controls (AEC)
  • Passive Engineered Controls (PEC)
  • Administrative Controls (ADM)
  • Types of Controls - Nonsafety-Related
  • Defense-in-Depth (DID)

SHINE Medical Technologies I 5

Current Status of the Integrated Safety Analysis

  • Hazard identification and evaluations completed
  • Process Hazard Analysis completed
  • Safety-related controls drafted and in review
  • Integrated Safety Analysis Summary Report drafted and in review
  • sHINE Medical Technologies I6

Security-Related Information - Withheld Under 10 CFR § 2.390 Example Process Hazard Analysis Accident Sequences

  • Inadvertent Reactivity Insertion or Criticality Security-Related Information SHINE Medical Technologies I 7

Security-Related Information - Withheld Under 10 CFR § 2.390 Example Process Hazard Analysis Accident Sequences

  • Deflagration and Detonation Security-Related Information SHINE Medical Technologies I 8

Security-Related Information - Withheld Under 10 CFR § 2.390

-~

Example Process Hazard Analysis Accident Sequences

  • Reduction in Cooling Security-Related Information SHINE Medical Technologies I 9

Security-Related Information - Withheld Under 10 CFR § 2.390 Discussion of Draft Safety-Related Controls Security-Related Information SHINE Medical Technologies j10

Security-Related Information - Withheld Under 10 CFR § 2.390 Discussion of Draft Safety-Related Controls Security-Related Information SHINE Medical Technologies j11